Abstract
Studies of the effects of psychoactive drugs have contributed much to the present knowledge of the role of catecholamines in behavioral physiology. Since drugs are never completely specific, i.e., no drug acts on only one system in the brain, the knowledge derived from pharmacological experiments is beset with a corresponding uncertainty. Evidence from several experiments, preferably carried out using very different methods, is therefore necessary for conclusions about association between a specific system in the brain and a certain behavior. In the following we shall try to expound such evidence about the association of catecholaminergic systems in the brain with behavioral activation and stereotypy, and we shall explore the possible relations of animal experiments with clinical observations comprising also mental phenomena such as thinking and mood.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alarcon, R. de, and Carney, M. W. P., 1969, Severe depressive mood changes following slow-release intramuscular fluphenazine injection, Brit. Med. J. 3: 564.
Anggàrd, E., Jönsson, L. E., and Gunne, L.-M., 1971, Pharmacological blockade of amphetamine effects in subjects dependent on central stimulants, Acta Pharmacol. Toxicol. Suppl. 4: 2.
Angrist, B., 1974, Amphetamine Psychosis, in: Catecholamines and Their Enzymes in the Neuropathology of Schizophrenia (S. Kety and S. Matthysse, eds.), J. Psychiat. Res. 11: 1.
Angrist, B., Schweitzer, J., Friedhoff, A. J., Gershon, S., Hekimian, L. J., and Floyd, A., 1969, The clinical symptomatology of amphetamine psychosis and its relationship to amphetamine levels in urine, Int. Pharmacopsychiatry 2:125.
Anlezark, G. M., Arbuthnott, G. W., Christie, J. E., and Crow, T. J., 1971, Role of cerebral dopamine in action of psychotropic drugs, Brit. J. Pharmacol. 41: 406.
Arnfred, T., and Randrup, A., 1968, Cholinergic mechanism in brain inhibiting amphetamine-induced stereotyped behavior, Acta Pharmacol. Toxicol. 26: 384.
Ashcroft, G. W., et al., 1972, Modified amine hypothesis for the etiology of affective illness, Lancet 1972: 573.
Ayhan, I. H., and Randrup, A., 1972, Role of brain noradrenaline in morphine-induced stereotyped behavior, Psychopharmacologia 27: 203.
Ayhan, I. H., and Randrup, A., 1973a, Behavioral and pharmacological studies on morphine-induced excitation of rats. Possible relation to brain catecholamines, Psychopharmacologia 29: 317.
Ayhan, I. H., and Randrup, A., 1973b, Inhibitory effects of amphetamine, L-dopa and apomorphine on morphine-induced behavioral excitation of rats, Arch. Intern. Pharmacodyn. 204: 283.
Benkert, 0., 1969, Measurement of hyperactivity in rats in a dose-response curve after intrahypothalamic norepinephrine injection, Life Sci. 8: 943.
Bleuler, M., 1972, Lehrbuch der Psychiatrie, Springer-Verlag, Berlin, Heidelberg, New York. Boardman, R. H., and Fullerton, A. G., 1960, Iatrogenic parkinsonism, J. Mental Sci. 106: 1468.
Bobon, J., Pinchard, A., Collard, J., and Bobon, D. P., 1972, Clinical classification of neuroleptics, with special reference to their antimanic, antiautistic, and ataraxic properties. Comprehensive Psychiat. 13: 123.
Bobon, J., Bobon, D. P., Pinchard, A., Collard, J., Ban, T. A., Buck, R. de, Hippius, H., Lambert, P. A., and Vinar, O., 1972a, A new comparative physiognomy of neuroleptics: a collaborative clinical report. Acta Psychiat. Belgica 72: 542.
Bohaeek, N., 1965, Discussion working group 4, in: Neuro-Psychopharmacology, ( D. Bente and P. B. Bradley, eds.), pp. 175–178, Elsevier Publishing Company, Amsterdam.
Bowers, M. B., Jr., 1973, 5-Hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) following probenecid in acute psychotic patients treated with phenothiazines, Psychopharmacologia 28: 309.
Caine, D. B., 1970, L-Dopa in the treatment of parkinsonism, Clin. Pharmacol. Therap. 11: 6.
Carlsson, A., Persson, T., Roos, B. E., and Wâlinder, J., 1972, Potentiation of phenothiazines by a-methyltyrosine in treatment of chronic schizophrenia, J. Neural Transmission 33: 83.
Carroll, B. J., and Sharp, P. T., 1972a, Monoamine mediation of the morphine-induced activation of mice, Brit. J. Pharmacol. 46: 124.
Carroll, B. J., and Sharp, P. T., 1972b, An animal model of mania, Psychopharmacologia 26 (Suppl. 1972): 10.
Cole, J. O., and Davis, J. M., 1968, Clinical efficacy of the phenothiazines as antipsychotic drugs, in: Psychopharmacology, (D. H. Efron, ed.), pp. 1057–1063, Public Health Service Publ. No. 1836, U.S. Government, Printing Office, Washington, D.C.
Connell, P. H., 1956, Amphetamine psychosis, Thesis, Maudsley Hospital, University of London.
Cools, A. R., 1971, The function of dopamine and its antagonism in the caudate nucleus of cats in relation to the stereotyped behaviour, Arch. Intern. Pharmacodyn, 194: 259.
Cools, A. R., 1973, The Caudate Nucleus and Neurochemical Control of Behavior, Thesis, Universitet Nijmegen, Holland.
Costall, B. and Naylor, R. J., 1974, Extrapyramidal and mesolimbic involvement with the stereotypic activity of d-and 1-amphetamine, European J. Pharmacol. 25: 121.
Crow, T. J., 1972, A map of the rat mesencephalon for electrical self-stimulation, Brain Res. 36: 265.
Daube, H., 1942, Pervitinpsychosen, Nervenarzt 15: 20.
Delay, J., Pichot, P., Lemperiere, T., and Bailly, R., 1963, L’emploi des butyrophenones en psychiatrie etude statistique et psychometrique, in: Symposium Internazionale Sull’Haloperido! E Triperidol, pp. 305-319, Istituto Luso Farmaco D’Italia, Milano.
Dyne, L. J., and Hughes, R. N., 1970, Effects of methylphenidate on activity and reactions to novelty in rats, Psychonomic Sci. 19 (5): 267.
Ellinwood, E. H., 1967, Amphetamine psychosis: I. Description of the individuals and process, J. Nervous Mental Disease 144: 273.
Ellinwood, E. H., 1969, Amphetamine psychosis: A multi-dimensional process, Seminars Psychiatry 1: 208.
Ellinwood, E. H., 1971, Comparative methamphetamine intoxication in experimental animals, Pharmakopsychiat. Neuropsychopharmakol. 4: 357.
Ellinwood, E. H. 1972, Amphetamine psychosis: individuals, setting, and sequences, in: Current Concepts of Amphetamine Abuse,(E. H. Ellinwood, and S. Cohen, eds.), pp. 143–157, U.S. Government Printing Office, Washington, D.C.
Ellinwood, E. H., and Cohen, S. (eds.), 1972, Current Concepts of Amphetamine Abuse, U.S. Government Printing Office, Washington, D.C.
Ellinwood, E. H., and Duarte-Escalante, 0., 1972, Chronic methamphetamine intoxication in three species of experimental animals, in: Current Concepts of Amphetamine Abuse, ( E. H. Ellinwood and S. Cohen, eds.), pp. 59–68, U.S. Government Printing Office, Washington, D.C.
Ellinwood, E. H., Sudilovsky, and Nelson, L. M., 1973, Evolving behavior in the clinical and experimental amphetamine (model) psychosis, Am. J. Psychiat. 730 (10): 1088.
Ernst, A. M., 1971, Chemical stimulation of central dopaminergic receptors in the striatal body of rats, in: The Correlation of Adverse Effects in Man with Observation in Animals (S. B. de Baker, ed.), pp. 18–23, Excerpta Med. Intern. Congr. Series 220, Amsterdam.
Ernst, A. M., 1972, Relationship of the central effect of dopamine on gnawing compulsion syndrome in rats and the release of serotonin, Arch. Intern. Pharmacodyn. 199: 219.
Fog, R., 1970, Behavioral effects in rats of morphine and amphetamine and of a combination of the two drugs, Psychopharmacologia 16: 305.
Fog, R., 1972, On stereotype and catalepsy: studies on the effect of amphetamines and neuroleptics in rats, Acta Neurol. Scand. Suppl. 48: 50 (Thesis).
Forrest, A., 1969, Depressive changes after fluphenazine treatment, Brit. Med. J. October:69. Fukui, K., and Tagaki, H., 1972, Effect of morphine on the cerebral contents of metabolites of dopamine in normal and tolerant mice: its possible relation to analgesic action, Brit. J. Pharmacol. 44: 45.
Fukui, K., Shiomi, H., and Tagaki, H., 1972, Effect of morphine on tyrosine hydroxylase activity in mouse brain, European J. Pharmacol. 19: 123.
Geyer, M., 1973, Dissociation of some behavioral effects of intraventricular dopamine and norepinephrine, Dissertation Abst. 33 (11): 5539.
Geyer, M. A., and Segal, D. S., 1973, Differential effects of reserpine and a-methyl-p-tyrosine on norepinephrine and dopamine induced behavioral activity, Psychopharmacologia 29: 131.
Goodwin, F. K., Post, R. M., Dunner, D. L., and Gordon, E. K., 1973, Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique, Am. J. Psychiat. 130 (1): 73.
Guinard, L., 1890, Action physiologique de la morphine chez le chat, C. R. Acad, Sci. (Paris) 111: 981.
Gunne, L. M., Änggârd, E., and Jönsson, L. E., 1970, Blockade of amphetamine effects in human subjects, in: International Institute on the Prevention and Treatment of Drug De pendence, I.C.A.A. ( A. Tongue and E. Tongue, eds.), pp. 249–255, Lausanne, Switzerland.
Gunne, L. M.,.Änggârd, E., and Jönsson, L. E., 1972, Clinical trials with amphetamine-blocking drugs. Psychiat. Neurol. Neurochir. 75: 225.
Harder, A., 1947, Uber Weckamin-Psychosen, Schweiz. Med. Wochschr. 37/38:982. Heimchen, H., and Hippius, H., 1967, Depressive Syndrome im Verlauf neuroleptischer Therapie, Nervenarzt 38 (10): 455.
Herman, Z. S., 1970, The effects of noradrenaline on rat’s behaviour, Psychopharmacologia 16: 369.
Hughes, R. N., 1972, Methylphenidate-induced inhibition of exploratory behaviour in rats, Life Sci. 11: 161.
Isbell, H., 1971, Clinical aspects of the various forms of nonmedical use of drugs, Anesthesia Analgesia Current Res. 50: 886.
Janssen, P. A. J., Niemegeers, C. J. E., and Schellekens, K. H. L., 1965, Is it possible to predict the clinical effects of neuroleptic drugs (major tranquilizers) from animal data? I. A rzneimit tel-Forsch. 15: 104.
Janssen, P. A. J., Niemegeers, C. J. E., Schellekens, K. H. L., and Lenaerts, F. M., 1967, Is it possible to predict the clinical effects of neuroleptic drugs (major tranquilizers) from animal data? IV, Arzneimittel-Forsch. 17: 841.
Jönsson, L. E., Änggârd, E., and Gunne, L.-M., 1971, Blockade of intravenous amphetamine euphoria in man, Clin. Pharmacol. Therap. 12: 889.
Kalus, F., 1950, Über die psychotischen Bilder bei chronischem Pervitinmissbrauch (II), Psychiat. Neurol. Med. Psychol. 2:138:
Kalus, F.; Kucher, I., and Zutt, J., 1942, Über Psychosen bei chronisher Pervitinmissbrauch, Nervenarzt 15: 8.
Kellner, E., 1960, Preludinsucht and Preludinpsychose, Ther. Ggw. 11: 524.
Kety, S., and Matthysse, S. (eds.), 1974, Catecholamines and their enzymes in the Neuropathology of Schizophrenia, J. Psychiatric Res. 11:1.
Kjellberg, B., and Randrup, A., 1971, The effects of amphetamine and pimozide, a neuroleptic, on the social behavior of vervet monkeys (ceropithecus sp), in: Advances in Neuro-Psychopharmacology, ( O. Vinai, Z. Votava, and P. B. Bradley, eds.), pp. 305–310, North-Holland Publishing Company, Amsterdam. Avicenum, Czechoslovak Medical Press, Prague.
Kjellberg, B., and Randrup, A., 1972a, Stereotypy with selective stimulation of certain items of behavior observed in amphetamine-treated monkeys (cercopithecus), Pharmakopsychiatr. Neuropsychopharmakol. 5: 1.
Kjellberg, B., and Randrup, A., 1972b, Changes in social behaviour in pairs of vervet monkeys (cercopithecus) produced by single, low doses of amphetamine, Psychopharmacologia Suppl. 26: 117.
Krueger, H., Eddy, N. B., and Sumwalt, M., 1941, The Pharmacology of the Opium Alkaloids, Part 1, Supplement 165, Public Health Reports, U.S. Government Printing Office, Washington, D.C.
Kuschinsky, K., and Hornykiewicz, 0., 1973, Morphine-induced locomotor activity in mice: involvement of central dopaminergic and noradrenergic neurons, in: IV Congress of the Polish Pharmacological Society ( Kuschinsky, K., and Hornykiewicz, 0., ed.), p. 27, Lodz.
Lat, J., 1965, The spontaneous exploratory reactions as a tool for psychopharmacological studies. A contribution towards a theory of contradictory results, in: Pharmacology of Conditioning, Learning and Retension ( M. Ya. Mikhel’son, V. G. Longo, and Z. Votava, eds.), pp. 47–66, Pergamon Press, Czechoslovak Medical Press, Prague.
Lyon, M., and Randrup, A., 1972, The dose-response effect of amphetamine upon avoidance behavior in the rat seen as a function of increasing stereotype, Psychopharmacologia 23: 334.
Mandell, A. J., Markham, C. H., Tallman, F. F., and Mandell, M. P., 1962, Motivation and ability to move, Am. J. Psychiat. 119: 554.
McKenzie, G. M., 1972, Role of the tuberculum olfactorium in stereotyped behavior induced by apomorphine in the rat, Psychopharmacologia 23: 212.
Mendels, J., Frazer, A., Fitzgerald, R. G., Ramsey, T. A., and Stokes, J. W., 1972, Biogenic amine metabolites in cerebrospinal fluid of depressed and manic patients, Science 175:1380.
Mindham, R. H. S., 1970, Psychiatric symptoms in Parkinsonism, J. Neurol. Neurosurg. Psychiat. 33: 188.
Müller-Calgan, H., and Hotovy, R., 1961, Verhaltensänderungen der Katze durch verschiedene zentralerregand wirkende Pharmaka, Arzneimittel-Forsch. 11: 642.
Müller-Fahlbusch, H., 1972, Klinische and Katamnestische Untersuchungen zum Parkinsonismus, Georg Thieme Verlag, Stuttgart.
Munkvad, I., and Randrup, A., 1966, The persistence of amphetamine stereotypies of rats in spite of strong sedation, Acta Psychiat. Scand. Suppl. 191: 178.
Munkvad, I., and Randrup, A., 1970, Evidence indicating the role of brain dopamine in the psychopharmacology of schizophrenic psychoses, in: PsihoJarmakologija 2 ( N. Bohacek, ed.), pp. 45–47, Medicinska Naklada, Zagreb.
Munkvad, I., Hein, G., and Herskin, B., 1971, The treatment of chronic schizophrenics with pimozide (Orap), Clin. Trials J. 8 (Suppl. II): 67.
Nielsen, E. B., and Lyon, M., 1973, Drinking behavior and brain dopamine: Antagonistic effect of a neuroleptic drug (Pimozide) upon amphetamine-or apomorphine-induced hypodipsia, Psychopharmacologia 33: 299.
Nordin, G., Ottosson, J.-O., and Ross, B.-E., 1971, Influence of convulsive therapy on 5hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid in endogeneous depression, Psychopharmacologia 20: 315.
Norton, S., 1967, An analysis of cat behaviour using chlorpromazine and amphetamine, Intern J. Neuropharmacol. 6: 307.
Nymark, M., 1972, Apomorphine provoked stereotypy in the dog, Psychopharmacologia 26: 361.
O’Flanagan, P. M., and Taylor, R. B., 1950, A case of recurrent psychosis associated with amphetamine addiction, J. Mental Sci. 96: 1033.
Papeschi, R., and McClure, D., 1971, Homovanillic and 5-hydroxyindoleacetic acid in cerebrospinal fluid of depressed patients. Arch. Gen. Psychiat. 25: 352.
Papeschi, R., Randrup, A., and Lal, S., 1974a, Effect of ECT on dopaminergic and noradrenergic mechanisms. I. Effect on the behavioral changes induced by reserpine, a-methyl-ptyrosine or amphetamie, Psychopharmacologia 35: 149.
Papeschi, R., Randrup A., and Munkvad, I., 19746, Effect of ECT on dopaminergic and noradrenergic mechanisms. II. Effect on dopamine and noradrenaline concentrations and turnovers, Psychopharmacologia 35:159.
Patrick, H. T., and and Levy, D. M., 1922, Parkinson’s disease, Arch. Neurol. Psychiat. 7: 711.
Pedersen, V., and Christensen, A. V., 1972, Antagonism of methyl-phenidate-induced stereotyped gnawing in mice, Acta Pharmacol. Toxicol. 31: 488.
Piaget, J., 1964, Six Etudes de Psychologie, Gonthier, Paris.
Post, R. M., Kotin, J., Goodwin, F. K., and Gordon, E. K., 1973, Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness, Am. J. Psychiat. 130 (1): 67.
Randrup, A., and Munkvad, I., 1965, Special antagonism of amphetamine-induced abnormal behaviour, Psychopharmacologia 7: 416.
Randrup, A., and Munkvad, I., 1967, Stereotyped activities produced by amphetamine in several animal species and man, Psychopharmacologia 11: 300.
Randrup, A., and Munkvad, I., 1968, Behavioural stereotypies induced by pharmacological agents, Pharmakopsychiat. Neuropsychopharmakol. 1: 18.
Randrup, A., and Munkvad, I., 1970, Biochemical, anatomical and psychological investigations of stereotyped behavior induced by amphetamine, in: Amphetamines and Related Compounds ( E. Costa and S. Garattini, eds.), pp. 695–713, Raven Press, New York.
Randrup, A., and Munkvad, I., 1971, Behavioural toxicity of amphetamine studied in animal experiments, in: The Correlation of Adverse Effects in Man with Observations in Animals (S. B. de Baker, ed.), pp. 6–16, Excerpta Med. Congr. Series No. 220, Amsterdam.
Randrup, A., and Munkvad, I., 1972, Evidence indicating an association between schizophrenia and dopaminergic hyperactivity in the brain, Orthomol. Psychiat. 1 (1): 2.
Randrup, A., and Munkvad, I., 1975, Stereotyped behavior, in: Section 25, International Encyclopedia of Pharmacology and Therapeutics (O. Hornykiewicz, ed.), Pergamon Press, Toronto (in press).
Randrup, A., and Munkvad, I., 1974, Pharmacology and physiology of stereotyped behavior, in: Catecholamines and Their Enzymes in the Neuropathology of Schizophrenia (S. Kety and S. Matthysse, eds.)J. Psychiatric Res. 11 :1.
Randrup, A., Munkvad, I., and Udsen, P., 1963, Adrenergic mechanisms and amphetamine-induced abnormal behaviour, Acta Pharmacol. Toxicol. 20: 145.
Randrup, A., Munkvad, I. and Scheel-Krüger, J., 1973, Mechanisms by which amphetamines produce stereotypy, aggression and other behavioural effects, in: Psychopharmacology, Sexual Disorders and Drug Abuse (T. Bau et al.,eds.), North Holland, Amsterdam, and Avicenum, Prague.
Robbins, T., and Iversen, S. D., 1973, A dissociation of the effects of d-amphetamine on loco-motor activity and exploration in rats, Psychopharmacologia 28: 155.
Robinson, P., and Daley, M., 1967, Apomorphine-induced reinforcement, Psychonomic Sci. 7: 117.
Roffler-Tarlov, S., Sharman, D. F., and Tegerdine, P., 1971, 3,4-Dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the mouse striatum: a reflection of intra-and extra-neuronal metabolism of dopamine?, Brit. J. Pharmacol. 42: 343.
Rolinski, Z., and Scheel-Krüger, J., 1973, The effect of dopamine and noradrenaline antagonists on amphetamine induced locomotor activity in mice and rats, Acta Pharmacol. Toxicol. 33: 385.
Roos, B. E., and Sjöström, R., 1969, 5-hydroxyindoleacetic acid (and homovanillic acid) levels in the cerebrospinal fluid after probenecid application in patients with manic-depressive psychosis, Pharmacol. Clin. 1: 153.
Rylander, G., 1969, Clinical and medico-criminological aspects of addition to central stimulating drugs, in: Abuse of Central Stimulants ( F. Sjoquist and M. Tottie, eds.), pp. 251–273, Almqvist and Wiksell, Stockholm.
Rylander, G., 1971, Stereotypy in man following amphetamine abuse, in: The Correlation of Adverse Effects in Man with Observations in Animals (S. B. de Baker, ed.), pp. 28–31, Excerpta Med. Internl. Congr. Series No. 220, Amsterdam.
Rylander, G., 1972, Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs, Psychiat. Neurol. Neurochir. 75: 203.
Sano, I., and Nagasaka, 1956, Uber chronische Weckaminsucht in Japan, Fortschr. Neurol. Psychiat. 24: 391.
Sayers, A. C., 1972, An investigation into hyperkinesia and akinesia induced by certain stimulant drugs, Thesis, University of Aston in Birmingham.
Scheel-Krüger, J., 1972, Behavioural and biochemical comparison of amphetamine derivatives
cocaine, benztropine and tricyclic antidepressant drugs, European J. Pharmacol. 18:63. Scher, J., 1966, Patterns and profiles of addiction and drug abuse, Arch. Gen. Psychiat. 15:539.
Schi¢rring, E., 1971, Amphetamine-induced selective stimulation of certain behaviour items with concurrent inhibition of others in an open-field test with rats, Behaviour 34: 1.
Schigrring, E., 1972, Social isolation and other behavioural changes in a group of three vervet monkeys (cercopithecus) produced by single, low doses of amphetamine, Psychopharmacologia Suppl. 26: 117.
Schi¢rring, E., An open-field study on spontaneous locomotion with amphetamine-treated rats, In preparation.
Schi¢rring, E., and Randrup, A., 1971, Social isolation and changes in the formation of groups induced by amphetamine in an open-field test with rats, Pharmakopsychiatr. Neuropsychopharmakol. 4: 2.
Segal, D. S., and Mandell, A. J., 1970, Behavioral activation of rats during intraventricular infusion of norepinephrine, Proc. Natl. Acad. Sci. (U.S.) 66: 289.
Segal, M., and Ropschitz, D., 1969, Depressive changes after fluphenazine treatment, Brit. Med. J. 3: 169.
Simonson, M., 1964, Phenothiazine depressive reaction, J. Neuropsychiat. 5: 259.
Sjöqvist, F., and Tottie, M., (eds.), 1969, Abuse of Central Stimulants, Almqvist and Wiksell, Stockholm.
Sjöström, R., 1972, Studier av mano-depressiv psykos, Forskning och Praktik (Sandoz) 4:102. Soudijn, W., and Wijngaarden, I. van, 1972, Localization of [3H]pimozide in the rat brain in relation to its anti-amphetamine potency, J. Pharm. Pharmacol. 24: 773.
Staehelin, J. E., 1941, Pervitin-Psychose, Z. Ges. Neurol. Psychiat. 173: 589.
Tatetsu, S., 1960, Pervitin-psychosen, Folia Psychiat. Neurol. Japon. Suppl. 6: 25.
Van, Praag, H. M., and Korf, J., 1971, Retarded depression and the dopamine metabolism, Psychopharmacologia 19: 199.
Warburton, J. W., 1967, Depressive symptoms in Parkinson patients referred for thalamotomy, J. Neurol. Neurosurg. Psychiat. 30: 368.
Willner, J. H., Samach, M., Angrist, B. M., Wallach, M. B., and Gershon, S., 1970, Drug-induced stereotyped behavior and its antagonism in dogs, Commun. Behay. Biol. 5: 135.
York, D. H., 1972, Dopamine receptor blockage—A central action of chloropromazine on striatal neurones, Brain Res. 37: 91.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Plenum Press, New York
About this chapter
Cite this chapter
Randrup, A., Munkvad, I., Fog, R., Ayhan, I.H. (1975). Catecholamines in Activation, Stereotypy, and Level of Mood. In: Friedhoff, A.J. (eds) Catecholamines and Behavior · 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3135-3_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3135-3_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3137-7
Online ISBN: 978-1-4684-3135-3
eBook Packages: Springer Book Archive